PSG — PharmaSGP Holding SE Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapHigh Flyer

Annual income statement for PharmaSGP Holding SE, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	60.6	62.6	63.2	65.3	85.8
Cost of Revenue
Gross Profit	54.1	56.7	57	58.9	76.8
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	41	40.2	49	50.4	68.1
Operating Profit	19.5	22.4	14.2	14.9	17.7
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	19.5	22.3	14.1	14.2	15.8
Provision for Income Taxes
Net Income After Taxes	14.7	16.7	10.6	10.7	12
Net Income Before Extraordinary Items
Net Income	14.7	16.7	10.6	10.7	12
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	14.7	16.7	10.6	10.7	12
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.25	1.41	0.992	0.995	0.976
Dividends per Share